retatrutide causing diarrhea More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Annals - Retatrutide, a triple-hormone

The subcutaneous injection technique used for Retatrutide is the same method used for insulin and many other medications, with decades of safety data supporting its simplicity

Research Use Notice: This product is sold exclusively for research and development use by qualified professionals

Together, we will explore the crucial aspects of managing weight loss with GLP-1 medications, ensuring that you feel supported and empowered every step of the way

Delivery charges for orders outside the UK may vary depending on location

Lisa 82lbs I feel great every day

The science is more complex than the headline suggests, highlighting the importance of looking beyond headlines and interpreting the full evidence base